- 期刊
- OpenAccess
Emerging Therapeutic Options for the Management of COPD
並列摘要
Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death worldwide and is projected to be the third by 2020. COPD is characterized by chronic airflow limitation caused by airway inflammation and parenchymal destruction that is usually progressive. Inhaled bronchodilators continue to be the mainstay of the current management of COPD. Safety and efficacy data of the recently approved medications including aclidinium, glycopyrronium, roflumilast, and indacaterol are reviewed here.
被引用紀錄
廖盈謹、陳信均、楊曉菁（2015）。慢性阻塞肺部疾病之新觀念。台灣專科護理師學刊，1(1)，57-63。https://www.airitilibrary.com/Article/Detail?DocID=P20150413001-201502-201504130023-201504130023-57-63
延伸閱讀
- Desai, U., Gothi, D., & Joshi, J. M. (2012). COPD Exacerbations: Clinical Management Options. Indian Journal of Clinical Medicine, (2012), 1-15. https://doi.org/10.4137/IJCM.S5476
- Schweiger, T. A. (2012). Present and Prospective Therapeutic Regimens for COPD. Clinical Medicine Insights: Therapeutics, 2012(), 113-130. https://doi.org/10.4137/CMT.S2106
- Katsenos, S., & Constantopoulos, S. H. (2011). Long-Term Oxygen Therapy in COPD: Factors Affecting and Ways of Improving Patient Compliance. Pulmonary Medicine, 2011(), 74-81. https://doi.org/10.1155/2011/325362
- 王憲華（2000）。Evaluation of the discharge planning intervention on COPD patients〔碩士論文，臺北醫學大學〕。華藝線上圖書館。https://www.airitilibrary.com/Article/Detail?DocID=U0007-1704200714450643
- 蘇經凱（2009）。The Relationship of COPD Guideline Compliance,Clinical Outcome and Medical Expenditure〔碩士論文，高雄醫學大學〕。華藝線上圖書館。https://www.airitilibrary.com/Article/Detail?DocID=U0011-2808200911523300